We are live on
!
Find out more
FDCC
Foster Dykema Cabot & Co Portfolio holdings
AUM
$827M
1-Year Est. Return
18.87%
This Fund
S&P 500
This Quarter
Est. Return
-1.16%
1 Year Est. Return
+18.87%
3 Year Est. Return
+34.03%
5 Year Est. Return
+67.09%
10 Year Est. Return
+162.67%
AUM
$385M
AUM Growth
-$23.4M
(-5.7%)
Cap. Flow
-$18.9M
Cap. Flow
% of AUM
-4.9%
Top 10 Holdings %
Top 10 Hldgs %
58.72%
Holding
91
New
3
Increased
30
Reduced
41
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$12.6M |
| 2 |
Amgen
AMGN
|
+$4.36M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.25M |
| 4 |
Alerian MLP ETF
AMLP
|
+$1.1M |
| 5 |
Procter & Gamble
PG
|
+$355K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Europe ETF
VGK
|
+$17.1M |
| 2 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$8.32M |
| 3 |
JPMorgan Chase
JPM
|
+$5.23M |
| 4 |
Wells Fargo
WFC
|
+$2.69M |
| 5 |
CVS Health
CVS
|
+$1.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.77% |
| 2 | Technology | 9.31% |
| 3 | Healthcare | 6.84% |
| 4 | Energy | 6.72% |
| 5 | Consumer Staples | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Intel
INTC
$460B
| $267K | 0.07% |
8,775
+1,275
| +17% | +$41.2K |
|
77
iShares Russell Mid-Cap ETF
IWR
$56.1B
| $266K | 0.07% |
6,256
| – | – |
|
78
Chevron
CVX
$383B
| $253K | 0.07% |
2,623
-740
| -22% | -$77.7K |
|
79
Baxter International
BAX
$13.8B
| $245K | 0.06% |
6,462
-920
| -12% | -$34.4K |
|
80
Vanguard Morningstar Small-Cap ETF
VB
$79.6B
| $241K | 0.06% |
1,980
-525
| -21% | -$64.5K |
|
81
iShares Russell 2000 ETF
IWM
$80.2B
| $236K | 0.06% |
1,893
-110
| -5% | -$13.7K |
|
82
Hershey
HSY
$35.9B
| $231K | 0.06% |
2,600
| – | – |
|
83
AbbVie
ABBV
$455B
| $220K | 0.06% |
+3,277
| New | +$214K |
|
84
iShares Russell 1000 Growth ETF
IWF
$120B
| $219K | 0.06% |
8,856
| – | – |
|
85
Donaldson
DCI
$10.7B
| $215K | 0.06% |
6,000
| – | – |
|
86
TJX Companies
TJX
$176B
| $213K | 0.06% |
+6,424
| New | +$214K |
|
87
Emerson Electric
EMR
$83.3B
| $204K | 0.05% |
3,672
+125
| +4% | +$7.34K |
|
|
ARIA
88
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $84K | 0.02% |
10,200
| – | – |
|
89
BP
BP
$114B
| – | – |
-6,823
| Closed | -$221K |
|
90
Rayonier
RYN
$6.43B
| – | – |
-9,683
| Closed | -$237K |
|
Similar funds
FBA
MAM
IWP
DBT
CCA
FMAEN1
WWM
RWA
Foster Dykema Cabot & Co's Q2 2015 Portfolio in Review
As of Q2 2015, Foster Dykema Cabot & Co held 91 positions worth $385M, down 5.7% from $409M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Foster Dykema Cabot & Co withdrew a net $18.9M in Q2 2015, closing 2 positions and reducing 41 holdings. Its most notable exit was Rayonier, an estimated $237K position sold in full.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Foster Dykema Cabot & Co opened a new position in Amgen worth $4.17M.
- Foster Dykema Cabot & Co's largest Q2 2015 buy was Amgen: 27,196 shares worth $4.17M.
- Foster Dykema Cabot & Co added most to iShares Core MSCI EAFE ETF in Q2 2015, an estimated $12.6M increase.
- Foster Dykema Cabot & Co's biggest Q2 2015 reduction was Vanguard FTSE Europe ETF, cutting an estimated $17.1M.
- Foster Dykema Cabot & Co fully exited Rayonier in Q2 2015, selling an estimated $237K.
- Foster Dykema Cabot & Co's ten largest holdings make up 59% of its $385M portfolio in Q2 2015.
- Foster Dykema Cabot & Co opened 3 new positions and closed 2 in Q2 2015.
- Foster Dykema Cabot & Co's portfolio value fell 5.7% quarter-over-quarter to $385M.
Based on Foster Dykema Cabot & Co's 13F filing for Q2 2015, filed 6 Aug 2015.